↓ Skip to main content

Novel Nanoparticle-Based Cancer Treatment, Effectively Inhibits Lung Metastases and Improves Survival in a Murine Breast Cancer Model

Overview of attention for article published in Frontiers in oncology, November 2021
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age and source (55th percentile)

Mentioned by

twitter
3 X users

Citations

dimensions_citation
7 Dimensions

Readers on

mendeley
11 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Novel Nanoparticle-Based Cancer Treatment, Effectively Inhibits Lung Metastases and Improves Survival in a Murine Breast Cancer Model
Published in
Frontiers in oncology, November 2021
DOI 10.3389/fonc.2021.761045
Pubmed ID
Authors

Sarah Kraus, Raz Khandadash, Raphael Hof, Abraham Nyska, Ekaterina Sigalov, Moshe Eltanani, Pazit Rukenstein, Ricarina Rabinovitz, Rana Kassem, Adam Antebi, Ofer Shalev, Moshe Cohen-Erner, Glenwood Goss, Arnoldo Cyjon

X Demographics

X Demographics

The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 11 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 11 100%

Demographic breakdown

Readers by professional status Count As %
Professor 1 9%
Professor > Associate Professor 1 9%
Student > Bachelor 1 9%
Student > Master 1 9%
Unknown 7 64%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 2 18%
Engineering 1 9%
Unknown 8 73%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 22 November 2021.
All research outputs
#20,604,578
of 26,178,577 outputs
Outputs from Frontiers in oncology
#9,633
of 22,922 outputs
Outputs of similar age
#318,891
of 448,572 outputs
Outputs of similar age from Frontiers in oncology
#547
of 1,483 outputs
Altmetric has tracked 26,178,577 research outputs across all sources so far. This one is in the 18th percentile – i.e., 18% of other outputs scored the same or lower than it.
So far Altmetric has tracked 22,922 research outputs from this source. They receive a mean Attention Score of 3.1. This one is in the 48th percentile – i.e., 48% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 448,572 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 24th percentile – i.e., 24% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 1,483 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 55% of its contemporaries.